prednisolone has been researched along with Devic Disease in 36 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and tolerability of azathioprine (AZA), mycophenolate mofetil (MMF), and cyclophosphamide (CTX) in patients with neuromyelitis optica spectrum disorder (NMOSD)." | 7.83 | Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study. ( Cui, LY; Fei, YY; Qiao, L; Ren, HT; Wang, Q; Xu, Y; Zhang, Y; Zhao, Y, 2016) |
| " Corticosteroids are inexpensive and promising drugs for relapse prevention in NMOSD, but few studies have analysed the efficacy of corticosteroids in NMOSD, especially regarding the appropriate dosing and tapering regimens." | 5.62 | Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy. ( Akaishi, T; Aoki, M; Fujihara, K; Kuroda, H; Misu, T; Nakashima, I; Nishiyama, S; Takahashi, T; Takai, Y, 2021) |
| "To compare the efficacy and tolerability of azathioprine (AZA), mycophenolate mofetil (MMF), and cyclophosphamide (CTX) in patients with neuromyelitis optica spectrum disorder (NMOSD)." | 3.83 | Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study. ( Cui, LY; Fei, YY; Qiao, L; Ren, HT; Wang, Q; Xu, Y; Zhang, Y; Zhao, Y, 2016) |
| " Eight serious adverse events were recorded, four events in three (16%) patients assigned rituximab (lumbar compression fracture and infection around nail of right foot [n=1], diplopia [n=1], and uterine cancer [n=1]) and four events in two (11%) people allocated to placebo (exacerbation of glaucoma and bleeding in the right eye chamber after surgery [n=1], and visual impairment and asymptomatic white matter brain lesion on MRI [n=1]); all patients recovered." | 2.94 | Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. ( Fukaura, H; Kiriyama, T; Maruyama, H; Misu, T; Mori, M; Nakashima, I; Nomura, K; Ochi, K; Oeda, T; Okada, K; Sawada, H; Shimizu, Y; Tahara, M; Umemura, A; Yamamoto, K, 2020) |
| "Devic neuromyelitis optica (NMO) or Devic's syndrome is an uncommon clinical syndrome associating unilateral or bilateral optic neuritis and transverse myelitis." | 2.44 | [Devic's neuromyelitis optica in children: a case report and review of the literature]. ( Ben Ammar, H; Ben Hlima, N; Ben Rhomdhane, W; Ben Salah, M; Chaabouni, M; Chouchane, C; Djemal, N; Karray, A, 2007) |
| " Corticosteroids are inexpensive and promising drugs for relapse prevention in NMOSD, but few studies have analysed the efficacy of corticosteroids in NMOSD, especially regarding the appropriate dosing and tapering regimens." | 1.62 | Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy. ( Akaishi, T; Aoki, M; Fujihara, K; Kuroda, H; Misu, T; Nakashima, I; Nishiyama, S; Takahashi, T; Takai, Y, 2021) |
| "Neuromyelitis optica spectrum disorder was diagnosed." | 1.56 | Neuromyelitis optica spectrum disorder and active tuberculosis. ( Connell, D; Day, S; Grieve, JK; O'Riordan, J, 2020) |
| "A recurrent attack of NMOSD and intracranial hemorrhage were concurrently diagnosed." | 1.46 | Neuromyelitis Optica Spectrum Disorder with Recurrent Intracranial Hemorrhage. ( Mito, Y; Nomura, T; Ohashi, I; Tajima, Y; Yabe, I; Yaguchi, H, 2017) |
| "We present a pediatric patent with NMO spectrum disorder in order to draw awareness to this potentially neurologi- cally devastating disease." | 1.43 | Neuromyelitis Optica Spectrum Disorder in a Pediatric Patient. ( Archer, R; Ramakrishnaiah, R; Willis, E, 2016) |
| "The diagnosis was neuromyelitis optica spectrum disorder (NMOSD)." | 1.43 | [Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis]. ( Fujihara, K; Nakamura, S; Oshiro, A; Tamashiro, K, 2016) |
| "Neuromyelitis optica is a rare, severe idiopathic disease that predominantly involves optic nerves and spinal cord." | 1.39 | Unusual manifestations of pediatric neuromyelitis optica. ( Kiresi, D; Yavuz, H, 2013) |
| "She was diagnosed as influenza A and was treated with zanamivir hydrate (10 mg/day, inhalation)." | 1.37 | Influenza-associated monophasic neuromyelitis optica. ( Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Nakamura, Y; Yoshii, Y, 2011) |
| "Devic's neuromyelitis optica is related to nosologic problems with multiple sclerosis." | 1.34 | [Devic's neuro-optic myelitis and pregnancy]. ( Bencherifa, F; Berraho, A; Bourassi, A; Mellal, Z, 2007) |
| "However, Devic's neuromyelitis optica has also been seen in children." | 1.34 | Devic's neuromyelitis optica in an infant case. ( Senbil, N; Yavuz Gurer, YK; Yilmaz, D; Yuksel, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 21 (58.33) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamagoe, K | 1 |
| Tanaka, M | 1 |
| Igari, K | 1 |
| Grieve, JK | 1 |
| Day, S | 1 |
| Connell, D | 1 |
| O'Riordan, J | 1 |
| Tahara, M | 1 |
| Oeda, T | 1 |
| Okada, K | 1 |
| Kiriyama, T | 1 |
| Ochi, K | 1 |
| Maruyama, H | 1 |
| Fukaura, H | 1 |
| Nomura, K | 1 |
| Shimizu, Y | 1 |
| Mori, M | 2 |
| Nakashima, I | 4 |
| Misu, T | 4 |
| Umemura, A | 1 |
| Yamamoto, K | 1 |
| Sawada, H | 1 |
| Takai, Y | 1 |
| Kuroda, H | 1 |
| Akaishi, T | 2 |
| Takahashi, T | 4 |
| Nishiyama, S | 1 |
| Fujihara, K | 5 |
| Aoki, M | 2 |
| Yaguchi, H | 1 |
| Mito, Y | 1 |
| Ohashi, I | 1 |
| Nomura, T | 1 |
| Yabe, I | 1 |
| Tajima, Y | 1 |
| Wang, L | 1 |
| Su, HJ | 1 |
| Qi, JL | 1 |
| E, RF | 1 |
| Zhao, K | 1 |
| Willis, E | 1 |
| Ramakrishnaiah, R | 1 |
| Archer, R | 1 |
| Alam, M | 1 |
| Haq, MAU | 1 |
| Iqbal, A | 1 |
| Ullah, K | 1 |
| Nabi, D | 1 |
| Kim, SM | 1 |
| Park, J | 1 |
| Kim, SH | 2 |
| Park, SY | 1 |
| Kim, JY | 1 |
| Sung, JJ | 1 |
| Park, KS | 1 |
| Lee, KW | 1 |
| Sakai, W | 1 |
| Matsui, N | 1 |
| Fujita, K | 1 |
| Izumi, Y | 1 |
| Nishida, Y | 1 |
| Kanbayashi, T | 1 |
| Kaji, R | 1 |
| Miyamoto, K | 3 |
| Oshiro, A | 1 |
| Nakamura, S | 1 |
| Tamashiro, K | 1 |
| Xu, Y | 1 |
| Wang, Q | 1 |
| Ren, HT | 1 |
| Qiao, L | 1 |
| Zhang, Y | 1 |
| Fei, YY | 1 |
| Zhao, Y | 1 |
| Cui, LY | 1 |
| Erol, İ | 1 |
| Özkale, M | 1 |
| Savaş, T | 1 |
| Alkan, Ö | 1 |
| Çekinmez, M | 1 |
| Erbay, A | 1 |
| Itoyama, Y | 1 |
| Simó, M | 1 |
| Kusunoki, S | 2 |
| Saida, T | 1 |
| Imbe, H | 1 |
| Nakajima, H | 1 |
| Ito, T | 1 |
| Kitaoka, H | 1 |
| Earnest, BS | 1 |
| Men, LC | 1 |
| Sukvinder Kaur, G | 1 |
| Alias, RB | 1 |
| Sunita Devi, H | 1 |
| Franciotta, D | 1 |
| Zardini, E | 1 |
| Caporali, R | 1 |
| Piccolo, L | 1 |
| Alberici, E | 1 |
| Romani, A | 1 |
| Bergamaschi, R | 1 |
| Marchioni, E | 1 |
| Ceroni, M | 1 |
| Piccolo, G | 1 |
| Nakamura, Y | 1 |
| Ikeda, K | 1 |
| Yoshii, Y | 1 |
| Ito, H | 1 |
| Hirayama, T | 1 |
| Kawabe, K | 1 |
| Kano, O | 1 |
| Iwasaki, Y | 1 |
| Kawaguchi, N | 1 |
| Uzawa, A | 1 |
| Nemoto, Y | 1 |
| Masuda, S | 1 |
| Kuwabara, S | 1 |
| Kim, W | 1 |
| Li, XF | 1 |
| Jung, IJ | 1 |
| Kim, HJ | 1 |
| Yavuz, H | 1 |
| Kiresi, D | 1 |
| Kitada, M | 1 |
| Suzuki, H | 1 |
| Ichihashi, J | 1 |
| Inada, R | 1 |
| Mitsui, Y | 1 |
| Oyama, H | 1 |
| Miwa, S | 1 |
| Noda, T | 1 |
| Sobajima, A | 1 |
| Kito, A | 1 |
| Maki, H | 1 |
| Hattori, K | 1 |
| Wada, K | 1 |
| Foroughipour, M | 1 |
| Nikbin, Z | 1 |
| Sahebari, M | 1 |
| Pezeshki Rad, M | 1 |
| Shoeibi, A | 1 |
| HUGUENIN, A | 1 |
| FOISSIN, J | 1 |
| FERRAND, J | 1 |
| COURTOIS, E | 1 |
| Bencherifa, F | 1 |
| Bourassi, A | 1 |
| Mellal, Z | 1 |
| Berraho, A | 1 |
| Yuksel, D | 1 |
| Senbil, N | 1 |
| Yilmaz, D | 1 |
| Yavuz Gurer, YK | 1 |
| Djemal, N | 1 |
| Ben Salah, M | 1 |
| Ben Hlima, N | 1 |
| Ben Rhomdhane, W | 1 |
| Ben Ammar, H | 1 |
| Chaabouni, M | 1 |
| Chouchane, C | 1 |
| Karray, A | 1 |
| Ahasan, HA | 1 |
| Rafiqueuddin, AK | 1 |
| Chowdhury, MA | 1 |
| Azhar, MA | 1 |
| Kabir, F | 1 |
| Muzumdar, RH | 1 |
| Joshi, S | 1 |
| Malik, S | 1 |
| Tank, SJ | 1 |
| Easow, B | 1 |
| Gibbs, AN | 1 |
| Moroney, J | 1 |
| Foley-Nolan, D | 1 |
| O'Connell, PG | 1 |
6 reviews available for prednisolone and Devic Disease
| Article | Year |
|---|---|
[Topics of neuromyelitis optica].
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodi | 2014 |
[Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Topics: Aquaporin 4; Astrocytes; Autoantibodies; Autoimmunity; Azathioprine; Biomarkers; Humans; Immunoglobu | 2009 |
[Therapy of multiple sclerosis].
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diagnosis, Differ | 2009 |
[Treatment of NMO].
Topics: Acute-Phase Reaction; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; | 2009 |
[Devic's neuromyelitis optica in children: a case report and review of the literature].
Topics: Azathioprine; Child; Evoked Potentials, Visual; Female; Glucocorticoids; Humans; Immunosuppressive A | 2007 |
Neuromyelitis optica with transient autonomic disturbances.
Topics: Anti-Inflammatory Agents; Autonomic Nervous System Diseases; Child; Humans; Magnetic Resonance Imagi | 2000 |
1 trial available for prednisolone and Devic Disease
| Article | Year |
|---|---|
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aquaporin 4; Disability Evaluation; Double-Blind Method; | 2020 |
29 other studies available for prednisolone and Devic Disease
| Article | Year |
|---|---|
Cases of aquaporin-4-positive neuromyelitis optica spectrum disorder with successful tapering of prednisolone to less than 3 mg/day after satralizumab administration.
Topics: Antibodies, Monoclonal, Humanized; Aquaporin 4; Autoantibodies; Humans; Neuromyelitis Optica; Predni | 2023 |
Neuromyelitis optica spectrum disorder and active tuberculosis.
Topics: Diagnosis, Differential; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Middle Aged; N | 2020 |
Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy.
Topics: Aquaporin 4; Aquaporins; Humans; Neuromyelitis Optica; Prednisolone; Retrospective Studies; Treatmen | 2021 |
Neuromyelitis Optica Spectrum Disorder with Recurrent Intracranial Hemorrhage.
Topics: Aquaporin 4; Autoantibodies; Female; Humans; Intracranial Hemorrhages; Middle Aged; Neuromyelitis Op | 2017 |
Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aquaporin 4; Autoantibodies; Female; Gluco | 2018 |
Neuromyelitis Optica Spectrum Disorder in a Pediatric Patient.
Topics: Adolescent; Azathioprine; Combined Modality Therapy; Diagnosis, Differential; Female; Glucocorticoid | 2016 |
Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
Topics: Adolescent; Aquaporin 4; Autoantibodies; Azathioprine; Female; Humans; Immunoglobulin G; Neuromyelit | 2019 |
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Azathi | 2013 |
[Case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion].
Topics: Adult; Aquaporin 4; Biomarkers; Brain; Humans; Inappropriate ADH Syndrome; Magnetic Resonance Imagin | 2014 |
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Topics: Adult; Aged; Carnitine; Chronic Disease; Comorbidity; Depression; Fatigue; Female; Gait Disorders, N | 2015 |
[Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
Topics: Autoantibodies; Azathioprine; Child; Humans; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycop | 2016 |
Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Topics: Adult; Azathioprine; Cyclophosphamide; Disability Evaluation; Female; Humans; Immunosuppressive Agen | 2016 |
Neuromyelitis optica mimics the morphology of spinal cord tumors.
Topics: Aquaporin 4; Autoantibodies; Azathioprine; Child; Diagnosis, Differential; Female; Glucocorticoids; | 2016 |
Intermittent plasmapheresis prevents recurrence in neuromyelitis optica.
Topics: Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Female; Humans; | 2009 |
[Neuromyelitis optica in a patient with Sjögren syndrome with distal renal tubular acidosis: case report].
Topics: Acidosis, Renal Tubular; Adult; Aquaporin 4; Autoantibodies; Biomarkers; Female; Humans; Methylpredn | 2010 |
Chronic hepatitis C infection associated with neuromyelitis optica and antinuclear antibodies.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Hepatitis C Antibodies; Hepatitis C, Chronic; Hum | 2010 |
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.
Topics: Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Facial Nerve Diseases; Female; Humans; | 2011 |
Influenza-associated monophasic neuromyelitis optica.
Topics: Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Aquaporin 4; Autoantibodies; Female; Humans; | 2011 |
Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report.
Topics: Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Female; Humans; Middle Aged; Neuromyelitis Op | 2012 |
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Autoimmunity; Azathiopri | 2012 |
Unusual manifestations of pediatric neuromyelitis optica.
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Brain; Choline; Diagnosis, Differential; Disease | 2013 |
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Topics: Acute Disease; Antibodies, Anti-Idiotypic; Aquaporin 4; Carbamazepine; Comorbidity; Female; Humans; | 2012 |
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography findings--case report.
Topics: Administration, Oral; Aquaporin 4; Autoantibodies; Cervical Vertebrae; Drug Therapy, Combination; Ed | 2012 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agen | 2012 |
[Optic neuromyelitis successfully treated with delta-1-hydrocortisone].
Topics: Humans; Hydrocortisone; Myelitis; Neuritis; Neuromyelitis Optica; Prednisolone | 1957 |
[Devic's neuro-optic myelitis and pregnancy].
Topics: Adult; Female; Glucocorticoids; Humans; Neuromyelitis Optica; Paraplegia; Prednisolone; Pregnancy; P | 2007 |
Devic's neuromyelitis optica in an infant case.
Topics: Atrophy; Demyelinating Autoimmune Diseases, CNS; Humans; Immunosuppressive Agents; Infant; Male; Mus | 2007 |
Neuromyelitis optica (Devic's disease) following chicken pox.
Topics: Adult; Chickenpox; Ephedrine; Female; Humans; Myelitis, Transverse; Neuromyelitis Optica; Prednisolo | 1994 |
Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive | 2002 |